Prevalence-First Microbiome Trial Analytics Service

A biostatistics service for microbiome drug trials that jointly tests whether taxa differ by presence (prevalence) or by amount (abundance), with false-discovery control and repeated-measures support — catching the majority of disease associations that abundance-only pipelines miss.